ILiAD Biotechnologies: Series BDeveloping a next-generation pertussis vaccine candidate BPZE1Oct 4, 2026RoundOSILiAD BiotechnologiesCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries B